Document Detail

Myocardial determinants in regulation of the heart rate.
MedLine Citation:
PMID:  9428618     Owner:  NLM     Status:  MEDLINE    
Heart rate is a function of at least three factors located in the sinus node, including the pacemaker and the activity of the sympathetic and vagal pathways. Heart rate varies during breathing and exercising. The is far from being a purely academic question because, after myocardial infarction or in cardiac insufficiency, reduced heart rate variability (HRV) represents the most valuable prognostic factor. HRV is usually considered index of the sympathovagal balance and is explored using time domain analysis, such as spectral analysis. Nevertheless, methods such as the Fast Fourier Transformation are not applicable to small rodents which have an unstable heart rate with asymmetric oscillations. Nonlinear methods show chaotic behavior under some conditions. A time and frequency domain method of analysis, the Wigner-Villé Transform, has been proposed for the study of HRV in both humans and small rodents, as a compromise between linear and nonlinear methods. We developed a method to quantify both arrhythmias and HRV in unanesthetized rodents. Such a method allows study of the relationship between the physiological parameters and the myocardial phenotype. Ventricular premature beats are more frequent in 16-month-old spontaneously hypertensive rats than in age-matched controls. In addition, HRV is attenuated in spontaneously hypertensive rats, as in compensatory cardiac hypertrophy in humans, and such attenuation is considered a prognostic index. Converting enzyme inhibition reduces in parallel arterial hypertension, cardiac hypertrophy, and ventricular fibrosis; it prevents ventricular premature beats and normalizes heart rate variability. It can be demonstrated that the incidence of ventricular premature beats is linked to the myocardial phenotype in terms of both cardiac hypertrophy and fibrosis. The two factors act as independent variables. HRV is correlated with the incidence of arrhythmias, suggesting that the beneficial effects of converting enzyme inhibition are related to prevention of arrhythmias.
B Swynghedauw; S Jasson; J Clairambault; B Chevalier; C Heymes; C Medigue; F Carré; P Mansier
Related Documents :
24961148 - Does off-pump coronary revascularization confer superior organ protection in re-operati...
12454788 - Cardiovascular effects associated with air pollution: potential mechanisms and methods ...
9784908 - Effect of verapamil on heart rate variability after an acute myocardial infarction. dan...
19859048 - The role of nuclear medicine technique in evaluating electrophysiology in diabetic hear...
19636688 - Electrophysiological characteristics associated with symptoms in pacemaker patients wit...
22193838 - Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in at...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of molecular medicine (Berlin, Germany)     Volume:  75     ISSN:  0946-2716     ISO Abbreviation:  J. Mol. Med.     Publication Date:    1997 Nov-Dec
Date Detail:
Created Date:  1998-02-09     Completed Date:  1998-02-09     Revised Date:  2011-07-08    
Medline Journal Info:
Nlm Unique ID:  9504370     Medline TA:  J Mol Med (Berl)     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  860-6     Citation Subset:  IM    
U 127-INSERM-Hopital Lariboisiére, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiomegaly / physiopathology
Disease Models, Animal
Heart Rate / physiology*
Models, Cardiovascular*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression.
Next Document:  Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease.